Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2012

01-09-2012 | Article

Clinical and epidemiological characteristics of adult patients hospitalized for erysipelas and cellulitis

Authors: M.-R. Perelló-Alzamora, J.-C. Santos-Duran, M. Sánchez-Barba, J. Cañueto, M. Marcos, P. Unamuno

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2012

Login to get access

Abstract

The purpose of this investigation was to analyze the clinical and epidemiological aspects of all cases of erysipelas and infectious cellulitis admitted to a tertiary hospital during a period of five years. All patients admitted with the main diagnosis of erysipelas or cellulitis to the Department of Dermatology of the author’s institution from January 2005 to May 2010 were included. Seventy patients were identified and their medical records were retrospectively reviewed so as to record the epidemiological and clinical data. Univariate and multivariable analyses were performed to analyze variables that predicted longer length of stay. The frequency of cellulitis in the lower limbs was higher in men and patients older than 65 years. Moderate/severe cellulitis in patients with basal comorbidity followed by a poor response to oral antibiotic therapy for 48 h were the most common reasons for admission. At arrival, four patients had abscessed areas. Fourteen patients developed local complications and 18 cases developed general in-hospital complications. Most patients improved or were healed with intravenous amoxicillin–clavulanate 1 g–200 mg/8 h. Intravenous amoxicillin–clavulanate 1 g–200 mg/8 h may be a good choice for empiric treatment in our setting. The development of in-hospital complications and the need for changing empiric antibiotic therapy were significant and independent variables associated with longer length of stay.
Literature
1.
go back to reference Stevens DL (2009) Treatments for skin and soft-tissue and surgical site infections due to MDR Gram-positive bacteria. J Infect 59(Suppl 1):S32–S39PubMedCrossRef Stevens DL (2009) Treatments for skin and soft-tissue and surgical site infections due to MDR Gram-positive bacteria. J Infect 59(Suppl 1):S32–S39PubMedCrossRef
2.
go back to reference Figtree M, Konecny P, Jennings Z, Goh C, Krilis SA, Miyakis S (2010) Risk stratification and outcome of cellulitis admitted to hospital. J Infect 60(6):431–439PubMedCrossRef Figtree M, Konecny P, Jennings Z, Goh C, Krilis SA, Miyakis S (2010) Risk stratification and outcome of cellulitis admitted to hospital. J Infect 60(6):431–439PubMedCrossRef
3.
go back to reference Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ et al (2005) Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 41(10):1373–1406PubMedCrossRef Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ et al (2005) Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 41(10):1373–1406PubMedCrossRef
4.
go back to reference Weigelt J, Itani K, Stevens D, Lau W, Dryden M, Knirsch C (2005) Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother 49(6):2260–2266PubMedCrossRef Weigelt J, Itani K, Stevens D, Lau W, Dryden M, Knirsch C (2005) Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother 49(6):2260–2266PubMedCrossRef
5.
go back to reference Carratalà J, Rosón B, Fernández-Sabé N, Shaw E, del Rio O, Rivera A et al (2003) Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis 22(3):151–157PubMed Carratalà J, Rosón B, Fernández-Sabé N, Shaw E, del Rio O, Rivera A et al (2003) Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis 22(3):151–157PubMed
6.
go back to reference Lazzarini L, Conti E, Tositti G, de Lalla F (2005) Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. J Infect 51(5):383–389PubMedCrossRef Lazzarini L, Conti E, Tositti G, de Lalla F (2005) Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. J Infect 51(5):383–389PubMedCrossRef
7.
go back to reference Lebre C, Girard-Pipau F, Roujeau JC, Revuz J, Saiag P, Chosidow O (1996) Value of fine-needle aspiration in infectious cellulitis. Arch Dermatol 132(7):842–843PubMedCrossRef Lebre C, Girard-Pipau F, Roujeau JC, Revuz J, Saiag P, Chosidow O (1996) Value of fine-needle aspiration in infectious cellulitis. Arch Dermatol 132(7):842–843PubMedCrossRef
8.
go back to reference Manzur A, Gudiol F (2009) Methicillin-resistant Staphylococcus aureus in long-term-care facilities. Clin Microbiol Infect 15(Suppl 7):26–30PubMedCrossRef Manzur A, Gudiol F (2009) Methicillin-resistant Staphylococcus aureus in long-term-care facilities. Clin Microbiol Infect 15(Suppl 7):26–30PubMedCrossRef
9.
go back to reference Tan R, Newberry DJ, Arts GJ, Onwuamaegbu ME (2007) The design, characteristics and predictors of mortality in the North of England Cellulitis Treatment Assessment (NECTA). Int J Clin Pract 61(11):1889–1893PubMedCrossRef Tan R, Newberry DJ, Arts GJ, Onwuamaegbu ME (2007) The design, characteristics and predictors of mortality in the North of England Cellulitis Treatment Assessment (NECTA). Int J Clin Pract 61(11):1889–1893PubMedCrossRef
Metadata
Title
Clinical and epidemiological characteristics of adult patients hospitalized for erysipelas and cellulitis
Authors
M.-R. Perelló-Alzamora
J.-C. Santos-Duran
M. Sánchez-Barba
J. Cañueto
M. Marcos
P. Unamuno
Publication date
01-09-2012
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2012
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1549-2

Other articles of this Issue 9/2012

European Journal of Clinical Microbiology & Infectious Diseases 9/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.